Literature DB >> 6338331

Hypotensive and vasodilatory activity of (+/-) 1-o-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat.

F M Lai, C A Shepherd, P Cervoni, A Wissner.   

Abstract

Synthetic (+/-) 1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine (octadecyl-AGPC) in microgram/kg doses given intravenously effectively and potently lowered mean arterial blood pressure in conscious and anesthetized normotensive rats. The hypotensive activity was much more pronounced in the anesthetized rat than in the conscious rat. The hypotension was associated with a significant elevation in plasma renin activity (PRA). In the rat in which the hindquarters were perfused, octadecyl-AGPC given intraarterially effectively decreased the perfusion and systemic pressures in a dose-dependent manner. Pharmacological blockade with specific cholinergic, histaminergic or beta-adrenergic receptor antagonists, did not block or attenuate the octadecyl-AGPC-induced reduction in perfusion or systemic pressure. These results suggest that the hypotensive activity of octadecyl-AGPC in the normotensive rat is the result of direct vasodilation and not the result of cholinergic, histaminergic or beta-adrenergic receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338331     DOI: 10.1016/0024-3205(83)90122-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.

Authors:  H Moritoki; T Hisayama; S Takeuchi; H Miyano; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

2.  Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.

Authors:  Yong-Ping Yang; Xue-Mei Ma; Chun-Ping Wang; Jun Han; Yin-Ying Lu; Yi Xiang; Shu-Hui Su; Yong-Yi Feng
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

3.  Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine.

Authors:  P Cervoni; H E Herzlinger; F M Lai; T K Tanikella
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

4.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

5.  Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro.

Authors:  P Cervoni; B M Goldstein; H Herzlinger; F M Lai; G J Quirk
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

6.  Inhibition by cardiolipins of platelet-activating factor-induced rabbit platelet activation.

Authors:  D Tsoukatos; C A Demopoulos; A D Tselepis; M C Moschidis; A Donos; A Evangelou; J Benveniste
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

7.  Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.

Authors:  K Noguchi; T Matsuzaki; N Shiroma; Y Ojiri; M Sakanashi
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 8.  The pathophysiological role and therapeutic implications of platelet activating factor in diseases of aging.

Authors:  C Kroegel; C Kortsik; N Kroegel; H Matthys
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.